APA (7th ed.) Citation

RE, P., RW, H., AJ, S., M, D., J, C., M, B., . . . SJ, B. (2024). Well controlled maternal inflammatory bowel disease does not increase the risk of abnormal neurocognitive outcome screening in offspring. Brain, behavior, & immunity - health, 40, 100827. https://doi.org/10.1016/j.bbih.2024.100827

Chicago Style (17th ed.) Citation

RE, Prentice, et al. "Well Controlled Maternal Inflammatory Bowel Disease Does Not Increase the Risk of Abnormal Neurocognitive Outcome Screening in Offspring." Brain, Behavior, & Immunity - Health 40 (2024): 100827. https://doi.org/10.1016/j.bbih.2024.100827.

MLA (9th ed.) Citation

RE, Prentice, et al. "Well Controlled Maternal Inflammatory Bowel Disease Does Not Increase the Risk of Abnormal Neurocognitive Outcome Screening in Offspring." Brain, Behavior, & Immunity - Health, vol. 40, 2024, p. 100827, https://doi.org/10.1016/j.bbih.2024.100827.